ANIX has a dual-platform approach. It has an FSHR‑targeted CAR‑T program for ovarian cancer and an α‑lactalbumin breast cancer vaccine. Their Phase 1 CAR‑T showed reasonable safety, as one patient remains alive after 24 months. Others have also exceeded the four‑month median survival. This means ANIX could start testing even higher doses, which might be even more effective.
The meme-stock frenzy is seemingly making a comeback in 2025 as investors once again chase unprofitable companies for their latest bets.
Canadian residential real estate offers overlooked opportunities for US investors amid shifting immigration trends. CAPREIT is a well-established REIT with stable occupancy, rising rents, and a solid 3.5% dividend yield backed by a 60% payout ratio and over 5% AFFO yield. Technical analysis shows no short-term price catalyst, but long-term dividend yield trends signal potential upside unless major negative events occur.
A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent glioblastoma, a rare event for a fatal brain cancer with few treatment options, researchers reported on Sunday.
Avis has rallied over 60% since my March buy call, driven by strong used car pricing and tariff tailwinds, now reaching my $100-$120 price target. Q1 results were weak due to soft commercial demand, but leisure bookings are improving; cost cuts and fleet reductions are helping utilization and margins. Avis's upside is highly levered to used car prices, but current valuation already reflects a 20% gain in residual values and optimistic scenarios.
Canadian Apartment Properties REIT's Q1 2025 showed high occupancy at 97.6%, despite a slight year-over-year decrease and a significant 26% increase in average monthly rent. NOI margin dropped to 62.4% due to higher utilities and taxes, but improvements are expected with the recent carbon tax removal. Growth in rent increases has slowed, with a weighted average change of 3.4% compared to 4.1% in 2024.
The decline in revenues in the Americas hurts CAR's top line in the first quarter of 2025.
Avis Budget Group, Inc. (NASDAQ:CAR ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants David Calabria - Senior Vice President, Corporate Finance and Treasurer Joe Ferraro - President and Chief Executive Officer Izzy Martins - Executive Vice President and Chief Financial Officer Conference Call Participants John Babcock - Bank of America Stephanie Moore - Jefferies Christoper Stathoulopoulos - Susquehanna International Group, LLP Joseph Padua - JPMorgan Chase Dan Levy - Barclays Lizzie Dove - Goldman Sachs Chris Woronka - Deutsche Bank Operator Greetings, and welcome to the Avis Budget Group's First Quarter 2025 Earnings Conference Call. At this time, all participants will be in listen-only mode.
The headline numbers for Avis Budget (CAR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avis Budget Group (CAR) came out with a quarterly loss of $14.35 per share versus the Zacks Consensus Estimate of a loss of $5.72. This compares to loss of $3.21 per share a year ago.
Avis Budget (CAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avis Budget Group's stock is benefiting from strategic fleet management, enabling it to deal with a turbulent supply chain.